An Alpha-lactalbumin supplement (1000 mg daily) was prescribed for a sample of 27 patients between 18 months and 6 years of age suffering from insomnia and epilepsy. After 3 months of intake, 17 patients reported an effective improvement in sleep, reporting lower sleep latency and lower frequency of night-time awakenings. Sleep disorders show a high prevalence in patients suffering from epilepsy and the management of such disorders is a priority in order to improve the quality of life of the patient and caregivers.
Year: 2019
Nationality: Italy
Download the document